A case of visceral leishmaniasis imported from Armenia
A. L. Rossina,
S. B. Chuelov,
N. V. Kondratenko,
E. V. Tselovalnikova,
A. V. Tebenkov,
S. V. Kolyagina,
N. A. Sokolova,
N. V. Nepokulchitskaya https://doi.org/10.22627/2072-8107-2023-22-3-66-70
Abstract
The relevance of the problem of visceral leishmaniasis is due to the severity of clinical manifestations, as well as the need for immediate etiotropic therapy. The aim of the work is to summarize the data available in the literature regarding the epidemiological situation of visceral leishmaniasis in the Republic of Armenia, taking into account the possibility of imported cases in the territory of the Russian Federation. Materials and methods: a review of domestic and foreign literature over the past 10 years, including Internet resources, was carried out and our own clinical observation of a child with relapsed visceral leishmaniasis imported from Armenia was presented. Conclusion. Visceral leishmaniasis is endemic for Transcaucasia, incl. for the Republic of Armenia, disease. Persons who have visited areas of high risk of infection with developed characteristic symptom complex, including fever, hepatosplenomegaly, pancytopenia, are subject to examination for visceral leishmaniasis. After the treatment, it is necessary to carry out dynamic monitoring.
About the Authors
A. L. Rossina
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
S. B. Chuelov
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow
N. V. Kondratenko
Children's Clinical Hospital №9 named G. N. Speransky
Russian Federation
Russian Federation
Moscow
E. V. Tselovalnikova
Children's Clinical Hospital №9 named G. N. Speransky
Russian Federation
Russian Federation
Moscow
A. V. Tebenkov
Children's Clinical Hospital №9 named G. N. Speransky
Russian Federation
Russian Federation
Moscow
S. V. Kolyagina
Children's Clinical Hospital №9 named G. N. Speransky
Russian Federation
Russian Federation
Moscow
N. A. Sokolova
Pirogov Russian National Research Medical University; Morozov Children's City Clinical Hospital of the Department of Health of the Moscow city
Russian Federation
Russian Federation
Moscow
N. V. Nepokulchitskaya
Morozov Children's City Clinical Hospital of the Department of Health of the Moscow city
Russian Federation
Russian Federation
Moscow
References
1. Human parasitic diseases (protozoa and helminthiasis): A guide for doctors. Under. ed. V.P. Sergieva, Yu.V. Lobzina, S.S. Kozlova. St. Petersburg: OOO «Izdatel'stvo Foliant», 2016:640. (In Russ.)
2. https://www.who.int/ru/news-room/fact-sheets/detail/leishmaniasis
3. Sukiasyan A., Keshishyan A., Manukyan D. et al. Re-Emerging foci of visceral leishmaniasis in Armenia — First molecular diagnosis of clinical samples. Parasitology. 2019; 146:1—8. DOI:10.1017/S0031182019000064.
4. Kuhls K., Moskalenko O., Sukiasyan A. et al. Microsatellite based molecular epidemiology of Leishmania infantum from re-emerging foci of visceral leishmaniasis in Armenia and pilot risk assessment by ecological niche modeling. PLOS Neglected Tropical Diseases. 2021; 15: e0009288. DOI: 10.1371/journal.pntd.0009288.
5. Alvar J., Velez I.D., Bern C. et al. Leishmaniasis Worldwide and Global Estimates of Its Incidence. PLoS ONE. 2012; 7(5): e35671.
6. Strelkova M.V., Ponirovsky E.N., Morozov E.N. et al. A narrative review of visceral leishmaniasis in Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, the Crimean Peninsula and Southern Russia. Parasites & Vectors. 2015; 8: 330.
7. Ponirovsky E.N., Strelkova M.V., Zavoykin V.D. and others. Epidemiological situation of leishmaniasis in the Russian Federation: the first reliable cases of transmission. Medical Рarasitology and Рarasitic Diseases. 2015; 3:2—7. (In Russ.)
8. https://iris.who.int/bitstream/handle/10665/342531/9789289053150-rus.pdf?sequence=1&isAllowed=y [Guidelines for case management and surveillance of leishmaniasis in the WHO European Region. World Health Organization, 2018. (In Russ.)]
9. Aronson N., Herwaldt B.L., Libman M. et al. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin. Infect. Dis. 2016; 63(12):1539—1557. doi: 10.1093/cid/ciw742.
10. Burza S., Sinha P.K., Mahajan R. et al. Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India. PLoS Negl. Trop. Dis. 2014. 8(1): e2536. doi: 10.1371/journal.pntd.0002536.
11. Kajaia M., Morse D.L., Kamkamidze G. et al. Risk factors for relapse of visceral leishmaniasis in Georgia. Trop. Med. Int. Health. 2011. 16(2):186—92. doi: 10.1111/j.1365-3156.2010.02694.x.
12. Naylor-Leyland G., Collin S.M., Gatluak F. et al. The increasing incidence of visceral leishmaniasis relapse in South Sudan: A retrospective analysis of field patient data from 2001—2018. PLoS Negl. Trop. Dis. 2022. 16(8):e0010696. doi: 10.1371/journal.pntd.0010696.
13. Simão J.C., Victória C., Fortaleza C.M.C.B. Predictors of relapse of visceral leishmaniasis in inner São Paulo State, Brazil. Int. J. Infect. Dis. 2020. 95:44—49. doi: 10.1016/j.ijid.2020.02.028.
14. Lebedeva T.M., Chuelov S.B., Sayfullin М.А., Rossina A.L., Zvereva N.N., Pylaeva E.Y., Volkova G.I., Ivanova Yu.N., Kryukova L.V., Litsev A.A., Karan L.S. Autochthonous visceral leishmaniasis in the Russian Federation and the role of polymerase chain reaction as an alternative diagnostic method. Detskie Infektsii=Children's Infections. 2022;21(4):43—48. (In Russ.)
Review
For citations:
Rossina A.L., Chuelov S.B., Kondratenko N.V., Tselovalnikova E.V., Tebenkov A.V., Kolyagina S.V., Sokolova N.A., Nepokulchitskaya N.V. A case of visceral leishmaniasis imported from Armenia. CHILDREN INFECTIONS. 2023;22(3):66-70. (In Russ.) https://doi.org/10.22627/2072-8107-2023-22-3-66-70
Views:
441
Email this article 